Tag: biomedical
-
App Offers Fast, Inexpensive Urinary Tract Infection Test
A system for identifying bacterial infections shows the system’s smartphone app and accompanying lab kit can detect urinary tract infections, including those with sepsis, in about an hour.
-
Virtual Reality Therapy Company Gains $5.1M in Early Funds
A company in the U.K. developing automated treatments for phobias using immersive virtual reality is raising £3.2 million ($US 5.1 million) in its first venture funding round.
-
Small Business Grant Supports Bone Fracture Technology
An award from National Institutes of Health is funding development of a new injected drug that promises to repair bone fractures without surgery.
-
Gene-Edited Stem Cells Reduce Cocaine Seeking, Overdoses
The genome-editing technique Crispr used with stem cells is shown to release enzymes that reduce cocaine-seeking behavior in lab mice and protect against overdoses.
-
Trial Testing Universal Nasal Spray Flu Vaccine in Children
A clinical trial is underway evaluating a vaccine given as a nasal spray among children and teens that promises to protect against multiple flu types.
-
Exosuit Designed for Personalized Walking Help
A wearable robotic exoskeleton designed into textiles to provide personalized assistance is shown in lab and field tests to reduce the amount effort needed to walk long distances.
-
Patents Awarded for Stem Cell Heart Disease Technologies
A company developing treatments for heart disease using stem cells to regenerate healthy heart tissue received two new patents for techniques supporting its core processes.
-
NIH Grant Aims to Make Drugs Taste Better, Not Bitter
A new award from National Institutes of Health funds a study to identify components in taste bud cells that block bitter taste sensations encountered in some drugs and foods.
-
Univ. Spin-Off Developing A.I.-Boosted Heart Monitor
A new enterprise in the U.K. is developing a wearable heart monitor that diagnoses irregular heart rhythms with artificial intelligence using cloud-based algorithms.
-
Gilead Gains Genome-Editing Hepatitis B Therapy
Biopharmaceutical company Gilead Sciences is acquiring a genome-editing technology for treating hepatitis-B, a viral disease affecting the liver.